 |
Previous Article | Next Article 
The Journal of Neuroscience, May 1, 2000, 20(9):3214-3220
Synucleins Are Developmentally Expressed, and -Synuclein
Regulates the Size of the Presynaptic Vesicular Pool in Primary
Hippocampal Neurons
Diane D.
Murphy,
Susan M.
Rueter,
John Q.
Trojanowski, and
Virginia M.-Y.
Lee
Center for Neurodegenerative Disease Research, Department of
Pathology and Laboratory Medicine, University of Pennsylvania Medical
School, Philadelphia, Pennsylvania 19104
-, -, and -Synuclein, a novel family of neuronal proteins,
has become the focus of research interest because -synuclein has
been increasingly implicated in the pathogenesis of Parkinson's and
Alzheimer's disease. However, the normal functions of the synucleins
are still unknown. For this reason, we characterized -, -, and
-synuclein expression in primary hippocampal neuronal cultures and
showed that the onset of - and -synuclein expression was delayed
after synaptic development, suggesting that these synucleins may not be
essential for synapse formation. In mature cultured primary neurons,
- and -synuclein colocalized almost exclusively with
synaptophysin in the presynaptic terminal, whereas little -synuclein
was expressed at all. To assess the function of -synuclein, we
suppressed expression of this protein with antisense oligonucleotide
technology. Morphometric ultrastructural analysis of the -synuclein
antisense oligonucleotide-treated cultures revealed a significant
reduction in the distal pool of synaptic vesicles. These data suggest
that one function of -synuclein may be to regulate the size of
distinct pools of synaptic vesicles in mature neurons.
Key words:
Lewy bodies; Parkinson's disease; primary neurons; synapse; synuclein; vesicle
Copyright © 2000 Society for Neuroscience 0270-6474/00/2093214-07$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
B. Spencer, R. Potkar, M. Trejo, E. Rockenstein, C. Patrick, R. Gindi, A. Adame, T. Wyss-Coray, and E. Masliah
Beclin 1 Gene Transfer Activates Autophagy and Ameliorates the Neurodegenerative Pathology in {alpha}-Synuclein Models of Parkinson's and Lewy Body Diseases
J. Neurosci.,
October 28, 2009;
29(43):
13578 - 13588.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Wright, X. Wang, and D. R. Brown
Unique copper-induced oligomers mediate alpha-synuclein toxicity
FASEB J,
August 1, 2009;
23(8):
2384 - 2393.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. M. Ferreon, Y. Gambin, E. A. Lemke, and A. A. Deniz
Interplay of {alpha}-synuclein binding and conformational switching probed by single-molecule fluorescence
PNAS,
April 7, 2009;
106(14):
5645 - 5650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Perlmutter, A. R. Braun, and J. N. Sachs
Curvature Dynamics of {alpha}-Synuclein Familial Parkinson Disease Mutants: MOLECULAR SIMULATIONS OF THE MICELLE- AND BILAYER-BOUND FORMS
J. Biol. Chem.,
March 13, 2009;
284(11):
7177 - 7189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bisaglia, S. Mammi, and L. Bubacco
Structural insights on physiological functions and pathological effects of {alpha}-synuclein
FASEB J,
February 1, 2009;
23(2):
329 - 340.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sato, J. Xu, S. Okuyama, L. B. Martinez, S. M. Walsh, M. T. Jacobsen, R. J. Swan, J. D. Schlautman, P. Ciborowski, and T. Ikezu
Spatial Learning Impairment, Enhanced CDK5/p35 Activity, and Downregulation of NMDA Receptor Expression in Transgenic Mice Expressing Tau-Tubulin Kinase 1
J. Neurosci.,
December 31, 2008;
28(53):
14511 - 14521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Jao, B. G. Hegde, J. Chen, I. S. Haworth, and R. Langen
Structure of membrane-bound {alpha}-synuclein from site-directed spin labeling and computational refinement
PNAS,
December 16, 2008;
105(50):
19666 - 19671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. McFarland, C. E. Ellis, S. P. Markey, and R. L. Nussbaum
Proteomics Analysis Identifies Phosphorylation-dependent {alpha}-Synuclein Protein Interactions
Mol. Cell. Proteomics,
November 1, 2008;
7(11):
2123 - 2137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kuwahara, A. Koyama, S. Koyama, S. Yoshina, C.-H. Ren, T. Kato, S. Mitani, and T. Iwatsubo
A systematic RNAi screen reveals involvement of endocytic pathway in neuronal dysfunction in {alpha}-synuclein transgenic C. elegans
Hum. Mol. Genet.,
October 1, 2008;
17(19):
2997 - 3009.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Tessari, M. Bisaglia, F. Valle, B. Samori, E. Bergantino, S. Mammi, and L. Bubacco
The Reaction of {alpha}-Synuclein with Tyrosinase: POSSIBLE IMPLICATIONS FOR PARKINSON DISEASE
J. Biol. Chem.,
June 13, 2008;
283(24):
16808 - 16817.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kawahara, M. Hashimoto, P. Bar-On, G. J. Ho, L. Crews, H. Mizuno, E. Rockenstein, S. Z. Imam, and E. Masliah
{alpha}-Synuclein Aggregates Interfere with Parkin Solubility and Distribution: ROLE IN THE PATHOGENESIS OF PARKINSON DISEASE
J. Biol. Chem.,
March 14, 2008;
283(11):
6979 - 6987.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Soper, S. Roy, A. Stieber, E. Lee, R. B. Wilson, J. Q. Trojanowski, C. G. Burd, and V. M.-Y. Lee
{alpha}-Synuclein-induced Aggregation of Cytoplasmic Vesicles in Saccharomyces cerevisiae
Mol. Biol. Cell,
March 1, 2008;
19(3):
1093 - 1103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. S. Gorbatyuk, S. Li, L. F. Sullivan, W. Chen, G. Kondrikova, F. P. Manfredsson, R. J. Mandel, and N. Muzyczka
The phosphorylation state of Ser-129 in human {alpha}-synuclein determines neurodegeneration in a rat model of Parkinson disease
PNAS,
January 15, 2008;
105(2):
763 - 768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ahmad, S. Attoub, M. N. Singh, F. L. Martin, and O. M. A. El-Agnaf
{gamma}-Synuclein and the progression of cancer
FASEB J,
November 1, 2007;
21(13):
3419 - 3430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. Gitler and J. Shorter
Prime Time for {alpha}-Synuclein
J. Neurosci.,
March 7, 2007;
27(10):
2433 - 2434.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Qin, D. Hu, S. Han, S. H. Reaney, D. A. Di Monte, and A. L. Fink
Effect of 4-Hydroxy-2-nonenal Modification on {alpha}-Synuclein Aggregation
J. Biol. Chem.,
February 23, 2007;
282(8):
5862 - 5870.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Kramer and W. J. Schulz-Schaeffer
Presynaptic {alpha}-Synuclein Aggregates, Not Lewy Bodies, Cause Neurodegeneration in Dementia with Lewy Bodies
J. Neurosci.,
February 7, 2007;
27(6):
1405 - 1410.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Larsen, Y. Schmitz, M. D. Troyer, E. Mosharov, P. Dietrich, A. Z. Quazi, M. Savalle, V. Nemani, F. A. Chaudhry, R. H. Edwards, et al.
{alpha}-Synuclein Overexpression in PC12 and Chromaffin Cells Impairs Catecholamine Release by Interfering with a Late Step in Exocytosis.
J. Neurosci.,
November 15, 2006;
26(46):
11915 - 11922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Vigneswara, J. D. Lowenson, C. D. Powell, M. Thakur, K. Bailey, S. Clarke, D. E. Ray, and W. G. Carter
Proteomic Identification of Novel Substrates of a Protein Isoaspartyl Methyltransferase Repair Enzyme
J. Biol. Chem.,
October 27, 2006;
281(43):
32619 - 32629.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Kontopoulos, J. D. Parvin, and M. B. Feany
{alpha}-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity
Hum. Mol. Genet.,
October 15, 2006;
15(20):
3012 - 3023.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Mazzulli, A. J. Mishizen, B. I. Giasson, D. R. Lynch, S. A. Thomas, A. Nakashima, T. Nagatsu, A. Ota, and H. Ischiropoulos
Cytosolic Catechols Inhibit {alpha}-Synuclein Aggregation and Facilitate the Formation of Intracellular Soluble Oligomeric Intermediates
J. Neurosci.,
September 27, 2006;
26(39):
10068 - 10078.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. L. Moulder, X. Jiang, A. A. Taylor, J. W. Olney, and S. Mennerick
Physiological activity depresses synaptic function through an effect on vesicle priming.
J. Neurosci.,
June 14, 2006;
26(24):
6618 - 6626.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Martin, Y. Pan, A. C. Price, W. Sterling, N. G. Copeland, N. A. Jenkins, D. L. Price, and M. K. Lee
Parkinson's Disease {alpha}-Synuclein Transgenic Mice Develop Neuronal Mitochondrial Degeneration and Cell Death
J. Neurosci.,
January 4, 2006;
26(1):
41 - 50.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. S. Ulmer and A. Bax
Comparison of Structure and Dynamics of Micelle-bound Human {alpha}-Synuclein and Parkinson Disease Variants
J. Biol. Chem.,
December 30, 2005;
280(52):
43179 - 43187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Fortin, V. M. Nemani, S. M. Voglmaier, M. D. Anthony, T. A. Ryan, and R. H. Edwards
Neural Activity Controls the Synaptic Accumulation of {alpha}-Synuclein
J. Neurosci.,
November 23, 2005;
25(47):
10913 - 10921.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. W. Shults, E. Rockenstein, L. Crews, A. Adame, M. Mante, G. Larrea, M. Hashimoto, D. Song, T. Iwatsubo, K. Tsuboi, et al.
Neurological and Neurodegenerative Alterations in a Transgenic Mouse Model Expressing Human {alpha}-Synuclein under Oligodendrocyte Promoter: Implications for Multiple System Atrophy
J. Neurosci.,
November 16, 2005;
25(46):
10689 - 10699.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-i. Kubo, V. M. Nemani, R. J. Chalkley, M. D. Anthony, N. Hattori, Y. Mizuno, R. H. Edwards, and D. L. Fortin
A Combinatorial Code for the Interaction of {alpha}-Synuclein with Membranes
J. Biol. Chem.,
September 9, 2005;
280(36):
31664 - 31672.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. H. Norris, B. I. Giasson, R. Hodara, S. Xu, J. Q. Trojanowski, H. Ischiropoulos, and V. M.-Y. Lee
Reversible Inhibition of {alpha}-Synuclein Fibrillization by Dopaminochrome-mediated Conformational Alterations
J. Biol. Chem.,
June 3, 2005;
280(22):
21212 - 21219.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. W. Doss-Pepe, L. Chen, and K. Madura
{alpha}-Synuclein and Parkin Contribute to the Assembly of Ubiquitin Lysine 63-linked Multiubiquitin Chains
J. Biol. Chem.,
April 29, 2005;
280(17):
16619 - 16624.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Greenbaum, C. L. Graves, A. J. Mishizen-Eberz, M. A. Lupoli, D. R. Lynch, S. W. Englander, P. H. Axelsen, and B. I. Giasson
The E46K Mutation in {alpha}-Synuclein Increases Amyloid Fibril Formation
J. Biol. Chem.,
March 4, 2005;
280(9):
7800 - 7807.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Yavich, H. Tanila, S. Vepsalainen, and P. Jakala
Role of {alpha}-Synuclein in Presynaptic Dopamine Recruitment
J. Neurosci.,
December 8, 2004;
24(49):
11165 - 11170.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Hodara, E. H. Norris, B. I. Giasson, A. J. Mishizen-Eberz, D. R. Lynch, V. M.-Y. Lee, and H. Ischiropoulos
Functional Consequences of {alpha}-Synuclein Tyrosine Nitration: DIMINISHED BINDING TO LIPID VESICLES AND INCREASED FIBRIL FORMATION
J. Biol. Chem.,
November 12, 2004;
279(46):
47746 - 47753.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Chandra, F. Fornai, H.-B. Kwon, U. Yazdani, D. Atasoy, X. Liu, R. E. Hammer, G. Battaglia, D. C. German, P. E. Castillo, et al.
Double-knockout mice for {alpha}- and {beta}-synucleins: Effect on synaptic functions
PNAS,
October 12, 2004;
101(41):
14966 - 14971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Fortin, M. D. Troyer, K. Nakamura, S.-i. Kubo, M. D. Anthony, and R. H. Edwards
Lipid Rafts Mediate the Synaptic Localization of {alpha}-Synuclein
J. Neurosci.,
July 28, 2004;
24(30):
6715 - 6723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Jao, A. Der-Sarkissian, J. Chen, and R. Langen
From The Cover: Structure of membrane-bound {alpha}-synuclein studied by site-directed spin labeling
PNAS,
June 1, 2004;
101(22):
8331 - 8336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Nuscher, F. Kamp, T. Mehnert, S. Odoy, C. Haass, P. J. Kahle, and K. Beyer
{alpha}-Synuclein Has a High Affinity for Packing Defects in a Bilayer Membrane: A THERMODYNAMICS STUDY
J. Biol. Chem.,
May 21, 2004;
279(21):
21966 - 21975.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Wilson, D. D. Murphy, B. I. Giasson, B. Zhang, J. Q. Trojanowski, and V. M.-Y. Lee
Degradative organelles containing mislocalized {alpha}- and {beta}-synuclein proliferate in presenilin-1 null neurons
J. Cell Biol.,
May 10, 2004;
165(3):
335 - 346.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. RECCHIA, P. DEBETTO, A. NEGRO, D. GUIDOLIN, S. D. SKAPER, and P. GIUSTI
{alpha}-Synuclein and Parkinson's disease
FASEB J,
April 1, 2004;
18(6):
617 - 626.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Saha, J. Hill, M. A. Utton, A. A. Asuni, S. Ackerley, A. J. Grierson, C. C. Miller, A. M. Davies, V. L. Buchman, B. H. Anderton, et al.
Parkinson's disease {alpha}-synuclein mutations exhibit defective axonal transport in cultured neurons
J. Cell Sci.,
March 1, 2004;
117(7):
1017 - 1024.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Baptista, M. R. Cookson, and D. W. Miller
Parkin and {alpha}-Synuclein: Opponent Actions in The Pathogenesis of Parkinson'S Disease
Neuroscientist,
February 1, 2004;
10(1):
63 - 72.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Sharon, I. Bar-Joseph, G. E. Mirick, C. N. Serhan, and D. J. Selkoe
Altered Fatty Acid Composition of Dopaminergic Neurons Expressing {alpha}-Synuclein and Human Brains with {alpha}-Synucleinopathies
J. Biol. Chem.,
December 12, 2003;
278(50):
49874 - 49881.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. F. Outeiro and S. Lindquist
Yeast Cells Provide Insight into Alpha-Synuclein Biology and Pathobiology
Science,
December 5, 2003;
302(5651):
1772 - 1775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Iwata, M. Maruyama, T. Akagi, T. Hashikawa, I. Kanazawa, S. Tsuji, and N. Nukina
Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies
Hum. Mol. Genet.,
October 16, 2003;
12(20):
2625 - 2635.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Mash, Q. Ouyang, J. Pablo, M. Basile, S. Izenwasser, A. Lieberman, and R. J. Perrin
Cocaine Abusers Have an Overexpression of alpha -Synuclein in Dopamine Neurons
J. Neurosci.,
April 1, 2003;
23(7):
2564 - 2571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Dauer, N. Kholodilov, M. Vila, A.-C. Trillat, R. Goodchild, K. E. Larsen, R. Staal, K. Tieu, Y. Schmitz, C. A. Yuan, et al.
From the Cover: Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP
PNAS,
October 29, 2002;
99(22):
14524 - 14529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. Cabin, K. Shimazu, D. Murphy, N. B. Cole, W. Gottschalk, K. L. McIlwain, B. Orrison, A. Chen, C. E. Ellis, R. Paylor, et al.
Synaptic Vesicle Depletion Correlates with Attenuated Synaptic Responses to Prolonged Repetitive Stimulation in Mice Lacking alpha -Synuclein
J. Neurosci.,
October 15, 2002;
22(20):
8797 - 8807.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Lotharius, S. Barg, P. Wiekop, C. Lundberg, H. K. Raymon, and P. Brundin
Effect of Mutant alpha -Synuclein on Dopamine Homeostasis in a New Human Mesencephalic Cell Line
J. Biol. Chem.,
October 4, 2002;
277(41):
38884 - 38894.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Lotharius and P. Brundin
Impaired dopamine storage resulting from {alpha}-synuclein mutations may contribute to the pathogenesis of Parkinson's disease
Hum. Mol. Genet.,
October 1, 2002;
11(20):
2395 - 2407.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Ribeiro, K. Carneiro, C. A. Ross, J. R. L. Menezes, and S. Engelender
Synphilin-1 Is Developmentally Localized to Synaptic Terminals, and Its Association with Synaptic Vesicles Is Modulated by alpha -Synuclein
J. Biol. Chem.,
June 21, 2002;
277(26):
23927 - 23933.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. G. Perez, J. C. Waymire, E. Lin, J. J. Liu, F. Guo, and M. J. Zigmond
A Role for alpha -Synuclein in the Regulation of Dopamine Biosynthesis
J. Neurosci.,
April 15, 2002;
22(8):
3090 - 3099.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. B. Cole, D. D. Murphy, T. Grider, S. Rueter, D. Brasaemle, and R. L. Nussbaum
Lipid Droplet Binding and Oligomerization Properties of the Parkinson's Disease Protein alpha -Synuclein
J. Biol. Chem.,
February 15, 2002;
277(8):
6344 - 6352.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Wolozin and N. Golts
Book Review: Iron and Parkinson's Disease
Neuroscientist,
February 1, 2002;
8(1):
22 - 32.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Perrin, W. S. Woods, D. F. Clayton, and J. M. George
Exposure to Long Chain Polyunsaturated Fatty Acids Triggers Rapid Multimerization of Synucleins
J. Biol. Chem.,
November 2, 2001;
276(45):
41958 - 41962.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Sharon, M. S. Goldberg, I. Bar-Josef, R. A. Betensky, J. Shen, and D. J. Selkoe
alpha -Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins
PNAS,
July 31, 2001;
98(16):
9110 - 9115.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Tabrizi, M. Orth, J. M. Wilkinson, J.-W. Taanman, T. T. Warner, J. M. Cooper, and A. H.V. Schapira
Expression of mutant {alpha}-synuclein causes increased susceptibility to dopamine toxicity
Hum. Mol. Genet.,
November 1, 2000;
9(18):
2683 - 2689.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Jo, J. McLaurin, C. M. Yip, P. St. George-Hyslop, and P. E. Fraser
alpha -Synuclein Membrane Interactions and Lipid Specificity
J. Biol. Chem.,
October 27, 2000;
275(44):
34328 - 34334.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Perrin, W. S. Woods, D. F. Clayton, and J. M. George
Interaction of Human alpha -Synuclein and Parkinson's Disease Variants with Phospholipids. STRUCTURAL ANALYSIS USING SITE-DIRECTED MUTAGENESIS
J. Biol. Chem.,
October 27, 2000;
275(44):
34393 - 34398.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Biere, S. J. Wood, J. Wypych, S. Steavenson, Y. Jiang, D. Anafi, F. W. Jacobsen, M. A. Jarosinski, G.-M. Wu, J.-C. Louis, et al.
Parkinson's Disease-associated alpha -Synuclein Is More Fibrillogenic than beta - and gamma -Synuclein and Cannot Cross-seed Its Homologs
J. Biol. Chem.,
October 27, 2000;
275(44):
34574 - 34579.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Ellis, P. L. Schwartzberg, T. L. Grider, D. W. Fink, and R. L. Nussbaum
alpha -Synuclein Is Phosphorylated by Members of the Src Family of Protein-tyrosine Kinases
J. Biol. Chem.,
February 2, 2001;
276(6):
3879 - 3884.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. N. Uversky, J. Li, and A. L. Fink
Evidence for a Partially Folded Intermediate in alpha -Synuclein Fibril Formation
J. Biol. Chem.,
March 30, 2001;
276(14):
10737 - 10744.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Nielsen, H. Vorum, E. Lindersson, and P. H. Jensen
Ca2+ Binding to alpha -Synuclein Regulates Ligand Binding and Oligomerization
J. Biol. Chem.,
June 15, 2001;
276(25):
22680 - 22684.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Y. Sung, J. Kim, S. R. Paik, J. H. Park, Y. S. Ahn, and K. C. Chung
Induction of Neuronal Cell Death by Rab5A-dependent Endocytosis of alpha -Synuclein
J. Biol. Chem.,
July 13, 2001;
276(29):
27441 - 27448.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|